1
|
Morgan JA, Biggio JR, Martin JK, Mussarat N, McCloskey S, Williams FB. Utility of Weekly Laboratory Monitoring in the Expectant Management of Hypertensive Disorders of Pregnancy. Obstet Gynecol 2023; 142:1450-1453. [PMID: 37708501 DOI: 10.1097/aog.0000000000005372] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2023] [Accepted: 07/06/2023] [Indexed: 09/16/2023]
Abstract
Our retrospective cohort study evaluates the diagnostic yield of weekly laboratory surveillance in outpatient management of hypertensive disorders of pregnancy (HDP) based on patient clinical status at the time of laboratory testing. The study included 459 patients and 1,082 laboratory episodes: 356 (32.9%) episodes were performed in the setting of concerning clinical findings and 726 (67.1%) when the patient was asymptomatic. Overall, the diagnostic yield for abnormal laboratory values (n=11) was 1.0% (95% CI 0.4-1.6%) of all assessments performed and 2.4% (95% CI 1.0-3.8%) among all patients in the cohort. The prevalence of abnormal test results was higher in patients with clinical findings (2.8%, 95% CI 1.1-4.5%) compared with those who were asymptomatic (0.1%, 95% CI 0-0.2%) ( P <.01). Clinical findings suggestive of worsening disease had a 91% sensitivity (95% CI 59-100%) and a 99% (95% CI 99-100%) negative predictive value for abnormal laboratory values. Directed screening based on signs and symptoms, rather than universal weekly screening, may be a potential strategy to lower costs and reduce multiple blood draws for patients with HDP, because there is a low diagnostic yield for this practice.
Collapse
Affiliation(s)
- John A Morgan
- Department of Maternal-Fetal Medicine, Ochsner Clinic Foundation, New Orleans, Louisiana
| | | | | | | | | | | |
Collapse
|
2
|
Mussarat N, Biggio J, Martin J, Morgan J, Tivis R, Elmayan A, Williams FB. Masked pregnancy-associated hypertension as a predictor of adverse outcomes. Am J Obstet Gynecol MFM 2023; 5:100976. [PMID: 37098390 DOI: 10.1016/j.ajogmf.2023.100976] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2023] [Revised: 04/12/2023] [Accepted: 04/18/2023] [Indexed: 04/27/2023]
Abstract
BACKGROUND Masked hypertension has been described in nonpregnant populations as elevated blood pressure in the home setting that is not reproduced on clinical assessment. Patients with masked hypertension have a greater risk of cardiovascular morbidity than patients who have blood pressures within normal range or those with white coat hypertension. OBJECTIVE This study aimed to determine whether masked pregnancy-associated hypertension detected on Connected Maternity Online Monitoring, a remote home blood pressure monitoring system, is associated with higher rates of hypertensive disorders of pregnancy during delivery admission and maternal and neonatal morbidities. STUDY DESIGN This was a retrospective cohort study of all patients on Connected Maternity Online Monitoring who delivered at 6 hospitals in a single healthcare system between October 2016 and December 2020. Patients were classified as having either normal blood pressure or masked pregnancy-associated hypertension. Masked pregnancy-associated hypertension was defined as remotely detected systolic blood pressure of ≥140 mm Hg or diastolic blood pressure of ≥90 mm Hg after 20 weeks of gestation on 2 occasions before diagnosis in a clinical setting. The chi-square test and Student t test were used for demographic and outcomes comparisons. Logistic regression was used to adjust outcomes by race, insurance, and body mass index. RESULTS A total of 2430 deliveries were included in our analysis, including 165 deliveries that met the criteria for masked pregnancy-associated hypertension. Clinically established pregnancy-associated hypertension, defined at the time of delivery, was more common in the masked pregnancy-associated hypertension group than in the normotensive group (66% vs 10%; adjusted odds ratio, 17.2; 95% confidence interval, 11.91-24.81). Patients with masked pregnancy-associated hypertension had higher rates of preeclampsia with severe features on delivery admission than normotensive patients (28% vs 2%; adjusted odds ratio, 23.35; 95% confidence interval, 14.25-38.26). Preterm delivery (16% vs 7%; adjusted odds ratio, 2.47; 95% confidence interval, 1.55-3.94), cesarean delivery(38% vs 26%; adjusted odds ratio, 1.58; 95% confidence interval, 1.13-2.23), small for gestational age (11% vs 5%; adjusted odds ratio, 2.27; 95% confidence interval, 1.31-3.94), and neonatal intensive care unit admission (8% vs 4%; adjusted odds ratio, 2.20; 95% confidence interval, 1.18-4.09) were more common among patients with masked pregnancy-associated hypertension than among normotensive patients. CONCLUSION With more outcomes research, remote blood pressure monitoring may prove to be an important tool in identifying pregnancies at risk of complications related to masked hypertension.
Collapse
Affiliation(s)
- Naiha Mussarat
- Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Ochsner Health Center - New Orleans, New Orleans, LA.
| | - Joseph Biggio
- Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Ochsner Health Center - New Orleans, New Orleans, LA
| | - Jane Martin
- Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Ochsner Health Center - New Orleans, New Orleans, LA
| | - John Morgan
- Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Ochsner Health Center - New Orleans, New Orleans, LA
| | - Rick Tivis
- Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Ochsner Health Center - New Orleans, New Orleans, LA
| | - Ardem Elmayan
- Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Ochsner Health Center - New Orleans, New Orleans, LA
| | - Frank B Williams
- Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Ochsner Health Center - New Orleans, New Orleans, LA
| |
Collapse
|
3
|
Williams FB, Kader MA, Dickson DM, Colgate ER, Alam M, Haque R, Petri WA, Kirkpatrick BD, Lee B. Maternal Breast Milk Secretor Phenotype Does Not Affect Infant Susceptibility to Rotavirus Diarrhea. Open Forum Infect Dis 2023; 10:ofad299. [PMID: 37333724 PMCID: PMC10270652 DOI: 10.1093/ofid/ofad299] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2023] [Accepted: 06/06/2023] [Indexed: 06/20/2023] Open
Abstract
Breast milk secretor status is associated with antibody seroconversion to oral rotavirus vaccination. Here, we were unable to detect a similar impact on risk of infant rotavirus diarrhea or vaccine efficacy through 2 years of life, underscoring limitations of immunogenicity assessment alone in evaluation of oral rotavirus vaccine response.
Collapse
Affiliation(s)
- Frank B Williams
- Vaccine Testing Center and Translational Global Infectious Diseases Research Center, Larner College of Medicine, University of Vermont, Burlington, Vermont, USA
| | - Md Abdul Kader
- International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh
| | - Dorothy M Dickson
- Vaccine Testing Center and Translational Global Infectious Diseases Research Center, Larner College of Medicine, University of Vermont, Burlington, Vermont, USA
| | - E Ross Colgate
- Vaccine Testing Center and Translational Global Infectious Diseases Research Center, Larner College of Medicine, University of Vermont, Burlington, Vermont, USA
| | - Masud Alam
- International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh
| | - Rashidul Haque
- International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh
| | - William A Petri
- Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA
| | - Beth D Kirkpatrick
- Vaccine Testing Center and Translational Global Infectious Diseases Research Center, Larner College of Medicine, University of Vermont, Burlington, Vermont, USA
| | - Benjamin Lee
- Vaccine Testing Center and Translational Global Infectious Diseases Research Center, Larner College of Medicine, University of Vermont, Burlington, Vermont, USA
| |
Collapse
|
4
|
Williams FB, Pierce H, McBride CA, DeAngelis J, McLean K. Quality Initiative to Reduce Failed Trial of Labor after Cesarean Using Calculated VBAC Success Likelihood. Am J Perinatol 2022; 40:575-581. [PMID: 36228652 DOI: 10.1055/a-1960-2797] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
OBJECTIVE Vaginal birth after cesarean can reduce morbidity associated with multiple cesarean deliveries. Failed vaginal birth after cesarean is associated with increased maternal and neonatal morbidity. The Maternal-Fetal Medicine Units Vaginal Birth After Cesarean calculator is a validated tool to predict the likelihood of successful trial of labor after cesarean. Predicted likelihood < 60% has been associated with increased maternal and neonatal morbidity. We sought to determine if formal incorporation of calculated vaginal birth after cesarean likelihood into patient-centered counseling would reduce failed vaginal birth after cesarean. STUDY DESIGN This is a quality improvement intervention at a single tertiary-care academic medical center, in which standardized patient counseling was implemented, facilitated by an electronic medical record template featuring patient-specific likelihood of vaginal birth after cesarean success. Term singleton pregnancies with history of one to two cesareans were included; those with contraindication to labor were excluded. Historical controls (January 2016-December 2018, n = 693) were compared with a postimplementation cohort (January 2019-April 2020, n = 328). Primary outcome was failed vaginal birth after cesarean. RESULTS Fewer patients in the postintervention cohort had a history of an arrest disorder (PRE: 48%, 330/693 vs. POST: 40%, 130/326, p = 0.03); demographics were otherwise similar, including the proportion of patients with <60% likelihood of success (PRE: 39%, 267/693, vs. POST: 38%, 125/326). Following implementation, induction of labor in patients with a <60% likelihood of successful vaginal birth after cesarean decreased from 17% (45/267) to 5% (6/125, p < 0.01). The proportion of failed vaginal birth after cesarean decreased from 33% (107/329) to 22% (32/143, p = 0.04). Overall vaginal birth after cesarean rate did not change (PRE: 32%, 222/693, vs. POST: 34%, 111/326, p = 0.52). CONCLUSION An intervention targeting provider counseling that included a validated vaginal birth after cesarean success likelihood was associated with decreased risk of failed trial of labor after cesarean without affecting overall vaginal birth after cesarean rate. KEY POINTS · Labored cesarean increases maternal morbidity.. · Application of the Maternal-Fetal Medicine Units (MFMU) calculator to antenatal counseling decreased labored cesarean.. · Application of the MFMU calculator to antenatal counseling did not decrease overall vaginal birth after cesarean rate..
Collapse
Affiliation(s)
- Frank B Williams
- Department of Obstetrics, Gynecology and Reproductive Services, University of Vermont, Burlington, Vermont
| | - Hayley Pierce
- Department of Obstetrics, Gynecology and Reproductive Services, University of Vermont, Burlington, Vermont
| | - Carole A McBride
- Department of Obstetrics, Gynecology and Reproductive Services, University of Vermont, Burlington, Vermont
| | - Justin DeAngelis
- Department of Obstetrics, Gynecology and Reproductive Services, University of Vermont, Burlington, Vermont
| | - Kelley McLean
- Department of Obstetrics, Gynecology and Reproductive Services, University of Vermont, Burlington, Vermont
| |
Collapse
|
5
|
Abstract
OBJECTIVE The objective of this study was to describe the safety profile and demographic data for a cohort of pregnant individuals who received an mRNA coronavirus disease 2019 (COVID-19) vaccine. STUDY DESIGN Prospective cohort study (with exposure matching) of individuals with active pregnancy who underwent immunization with a novel mRNA COVID-19 vaccine matched 1:2 with vaccinated age-matched female nonregnant controls was carried out. The primary outcome was defined as any vaccine-related complaints as defined in the original safety data. Secondary outcomes included specific complaints, COVID-19 screening test, and positive COVID-19 test. RESULTS Eighty-three vaccinated pregnant persons were age-matched with 166 female controls, all of whom were vaccinated between December 2020 and January, 2021. There was no difference in race or ethnicity between the groups. The mean body mass index of pregnant patients was lower than that of controls (26.1 vs. 29.2, p = 0.002). The frequency of complaints following vaccine administration was not different between pregnant and nonpregnant patients (18.1 vs. 16.9%, p = 0.201). Pregnant individuals were more likely to report fever (4.8 vs. 0.6%, p = 0.044) and gastrointestinal symptoms (4.8 vs. 0%, p = 0.012). CONCLUSIONS Side effect profiles of COVID-19 vaccine administration at our institution were relatively similar between pregnant and nonpregnant individuals and no serious complications occurred in either group. As COVID-19 infection in pregnancy can have significant morbidity, our data support the continued use of the vaccine for pregnant patients. KEY POINTS · Pregnant and nonpregnant women had a similar frequency of complaints.. · No serious adverse outcomes were observed in either group.. · Pregnant women were more likely to report fever and gastrointestinal side effects which may reflect gestationally mediated physiological responses to immunization..
Collapse
Affiliation(s)
- Angela Nakahara
- Ochsner Health, Department of Women's Services, New Orleans, Louisiana
| | - Joseph R Biggio
- Ochsner Health, Department of Women's Services, New Orleans, Louisiana
| | - Ardem Elmayan
- Ochsner Health, Department of Women's Services, New Orleans, Louisiana
| | - Frank B Williams
- Ochsner Health, Department of Women's Services, New Orleans, Louisiana
| |
Collapse
|
6
|
Reagan-Steiner S, Bhatnagar J, Martines RB, Milligan NS, Gisondo C, Williams FB, Lee E, Estetter L, Bullock H, Goldsmith CS, Fair P, Hand J, Richardson G, Woodworth KR, Oduyebo T, Galang RR, Phillips R, Belyaeva E, Yin XM, Meaney-Delman D, Uyeki TM, Roberts DJ, Zaki SR. Detection of SARS-CoV-2 in Neonatal Autopsy Tissues and Placenta. Emerg Infect Dis 2022; 28:510-517. [PMID: 35138244 PMCID: PMC8888232 DOI: 10.3201/eid2803.211735] [Citation(s) in RCA: 20] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023] Open
|
7
|
Williams FB, Kader A, Colgate ER, Dickson DM, Carmolli M, Uddin MI, Sharmin S, Islam S, Bhuiyan TR, Alam M, Nayak U, Mychaleckyj JC, Petri WA, Haque R, Qadri F, Kirkpatrick BD, Lee B. Maternal Secretor Status Affects Oral Rotavirus Vaccine Response in Breastfed Infants in Bangladesh. J Infect Dis 2020; 224:1147-1151. [PMID: 32157282 PMCID: PMC8561252 DOI: 10.1093/infdis/jiaa101] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2019] [Accepted: 03/04/2020] [Indexed: 02/07/2023] Open
Abstract
Secretor status controls mucosal histoblood group antigen expression and is associated with susceptibility to rotavirus diarrhea, with non-secretors less susceptible to symptomatic infection. The role of breast milk secretor status on oral live-attenuated rotavirus vaccine response in breastfed infants has not been explored. In a monovalent G1P[8] rotavirus vaccine (RotarixTM) trial in Bangladesh, rotavirus-specific plasma IgA antibody seroconversion rates were higher among infants of maternal non-secretors (39% vs 23%, P=0.001). Maternal status remained a significant predictor when correcting for infant status (P=0.002). Maternal secretor status should be considered when interpreting oral rotavirus vaccine responses in low- and middle-income settings.
Collapse
Affiliation(s)
- Frank B Williams
- The University of Vermont Vaccine Testing Center, Larner College of Medicine, University of Vermont; Burlington, VT, USA
| | - Abdul Kader
- International Centre for Diarrhoeal Disease Research, Bangladesh; Dhaka, Bangladesh
| | - E Ross Colgate
- The University of Vermont Vaccine Testing Center, Larner College of Medicine, University of Vermont; Burlington, VT, USA
| | - Dorothy M Dickson
- The University of Vermont Vaccine Testing Center, Larner College of Medicine, University of Vermont; Burlington, VT, USA
| | - Marya Carmolli
- The University of Vermont Vaccine Testing Center, Larner College of Medicine, University of Vermont; Burlington, VT, USA
| | | | - Salma Sharmin
- International Centre for Diarrhoeal Disease Research, Bangladesh; Dhaka, Bangladesh
| | - Shahidul Islam
- International Centre for Diarrhoeal Disease Research, Bangladesh; Dhaka, Bangladesh
| | | | - Masud Alam
- International Centre for Diarrhoeal Disease Research, Bangladesh; Dhaka, Bangladesh
| | - Uma Nayak
- Department of Public Health Sciences and Center for Public Health Genomics, University of Virginia; Charlottesville, VA, USA
| | - Josyf C Mychaleckyj
- Department of Public Health Sciences and Center for Public Health Genomics, University of Virginia; Charlottesville, VA, USA
| | - William A Petri
- Division of Infectious Diseases and International Health, University of Virginia; Charlottesville, VA, USA
| | - Rashidul Haque
- International Centre for Diarrhoeal Disease Research, Bangladesh; Dhaka, Bangladesh
| | - Firdausi Qadri
- International Centre for Diarrhoeal Disease Research, Bangladesh; Dhaka, Bangladesh
| | - Beth D Kirkpatrick
- The University of Vermont Vaccine Testing Center, Larner College of Medicine, University of Vermont; Burlington, VT, USA
| | - Benjamin Lee
- The University of Vermont Vaccine Testing Center, Larner College of Medicine, University of Vermont; Burlington, VT, USA
| |
Collapse
|
8
|
Williams FB, McBride CA, Badger GJ, Bernstein IM. Measures of adiposity correlate with renal filtration in young nulliparous women: An observational cohort study. Obes Sci Pract 2020; 6:70-75. [PMID: 32128244 PMCID: PMC7042107 DOI: 10.1002/osp4.375] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2019] [Revised: 09/09/2019] [Accepted: 09/28/2019] [Indexed: 11/06/2022] Open
Abstract
OBJECTIVE Renal hyperfiltration, which has been documented in severe obesity and obesity-associated hypertension, can occur with hypertensive disorders of pregnancy. Identification of prepregnancy risk factors for unrecognized renal hyperfiltration could inform screening and intervention strategies to protect against pregnancy complications. In young, healthy, nulliparous women, associations between associations between measures of adiposity, insulin resistance, and renal vascular resistance were thus evaluated. METHODS This is a secondary analysis of a prospective observational trial characterizing associations of prepregnancy and late-pregnancy maternal physiology. Seventy-nine nulligravid women aged 18-42 years without major medical conditions were assessed for percent android body fat using dual-energy X-ray absorption. Renal cortical vessel blood flow resistance index (CVRI) was determined using Doppler ultrasonography. Creatinine clearance was calculated from 24-hour urine collection. RESULTS Renal CVRI inversely correlates with body mass index (r = -0.23, p = 0.047), percent android fat (r = -0.30, p = 0.008), and supine pulse (r = -0.44, p < 0.001). Creatinine clearance is positively associated with BMI and HOMA-IR.In regression modeling, supine pulse (r2 = 0.22, p < 0.001) and cardiac index (r2 = 0.05, p = 0.045) predict renal CVRI, whereas HOMA-IR (r2 = 0.11, p = 0.008) and cardiac output (r2 = 0.06, p = 0.039) predict creatinine clearance. Measures of adiposity are not independently predictive of either measure. CONCLUSIONS In healthy young women, measures of adiposity and insulin resistance correlate positively with renal filtration. Preclinical manifestations of renal hyperfiltration may have implications for pregnancy outcomes.
Collapse
Affiliation(s)
- Frank B. Williams
- Department of Obstetrics, Gynecology and Reproductive Services, Larner College of MedicineUniversity of VermontBurlingtonVermont
| | - Carole A. McBride
- Department of Obstetrics, Gynecology and Reproductive Services, Larner College of MedicineUniversity of VermontBurlingtonVermont
| | - Gary J. Badger
- Department of Obstetrics, Gynecology and Reproductive Services, Larner College of MedicineUniversity of VermontBurlingtonVermont
| | - Ira M. Bernstein
- Department of Obstetrics, Gynecology and Reproductive Services, Larner College of MedicineUniversity of VermontBurlingtonVermont
| |
Collapse
|
9
|
Abstract
Objective We aimed to determine if fibroids in pregnancy, categorized by size, are associated with adverse obstetrical outcomes. Study Design Demographic, clinical, and delivery data were collected from charts of women with singleton gestations who delivered at >20 weeks gestation with fibroids identified at routine anatomy scan and their randomly selected age-matched controls. Largest fibroid diameter was used to categorize small fibroids (≤5 cm) and large fibroids (>5 cm). Results We included 450 patients: 264 patients with fibroids (174 small, 90 large fibroids) and 186 age-matched controls. Women with large fibroids had significantly greater blood loss than women with small fibroids and women with no fibroids (p-value <0.0001 and <0.0001 after adjusting for delivery mode). When fibroid size was compared individually, there was a significantly higher rate of primary cesarean section in both small and large fibroid groups when compared with women with no fibroids (p-values 0.044 and 0.003 after adjusting for body mass index). Conclusion Women with fibroids in pregnancy have higher rates of primary cesarean delivery and are at significant risk for increased blood loss at the time of delivery.
Collapse
Affiliation(s)
- Jane Martin
- Department of Obstetrics and Gynecology, Section of Maternal-Fetal Medicine, Ochsner Clinic Foundation, New Orleans, Louisiana
| | - Nicole D Ulrich
- Department of Obstetrics and Gynecology, Section of Maternal-Fetal Medicine, Ochsner Clinic Foundation, New Orleans, Louisiana
| | - Sheena Duplantis
- Department of Obstetrics and Gynecology, Section of Maternal-Fetal Medicine, Ochsner Clinic Foundation, New Orleans, Louisiana
| | - Frank B Williams
- Department of Obstetrics and Gynecology, Section of Maternal-Fetal Medicine, Ochsner Clinic Foundation, New Orleans, Louisiana
| | - Qingyang Luo
- Office of Biostatistical Support, The Center for Applied Health Services Research, Ochsner Clinic Foundation, New Orleans, Louisiana
| | - Robert C Moore
- Department of Obstetrics and Gynecology, Section of Maternal-Fetal Medicine, Ochsner Clinic Foundation, New Orleans, Louisiana
| |
Collapse
|
10
|
Martin J, Moore R, Duplantis S, Williams FB. 561: Outcomes of ultrasound identified uterine fibroids in pregnancy. Am J Obstet Gynecol 2016. [DOI: 10.1016/j.ajog.2015.10.605] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
11
|
Martel C, Robertson R, Williams FB, Moore RC, Clark A. Anesthetic Management of a Parturient with PHACE Syndrome for Cesarean Delivery. ACTA ACUST UNITED AC 2015; 5:176-8. [PMID: 26576049 DOI: 10.1213/xaa.0000000000000208] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
PHACE syndrome is a disorder that features posterior fossa malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. PHACE syndrome includes abnormalities in several organ systems that may influence anesthetic management. We discuss the anesthetic management of a 26-year-old woman with PHACE syndrome presenting for cesarean delivery. Management included careful airway examination, slowly dosed epidural anesthesia, close hemodynamic monitoring aided by a radial arterial line, and continuous intraoperative neurologic assessment.
Collapse
Affiliation(s)
- Colleen Martel
- From the Department of Anesthesia, Ochsner Clinic Foundation, Jefferson, Louisiana
| | | | | | | | | |
Collapse
|
12
|
Ver Hoef LW, Paige AL, Riley KO, Cure J, Soltani M, Williams FB, Kennedy RE, Szaflarski JP, Knowlton RC. Evaluating hippocampal internal architecture on MRI: inter-rater reliability of a proposed scoring system. Epilepsy Res 2013; 106:146-54. [PMID: 23916363 DOI: 10.1016/j.eplepsyres.2013.05.009] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2012] [Revised: 04/13/2013] [Accepted: 05/13/2013] [Indexed: 11/25/2022]
Abstract
BACKGROUND Asymmetry of hippocampal internal architecture (HIA) has been reported to be a frequent imaging finding in epilepsy patients with temporal lobe epilepsy (TLE) who exhibit other signs of hippocampal sclerosis. HIA asymmetry may also be an independent predictor of the side of seizure onset in patients with otherwise normal MRI scans. The study of HIA asymmetry and its relationship to the laterality of TLE would benefit from a reliable method of assessing the clarity of HIA in MRI scans. We propose a visual scoring system that rates HIA clarity from 1 (imperceptible) to 4 (excellent) and report the inter-rater reliability (IRR) of this system. METHODS In the initial preliminary phase of this study we examined IRR using a kappa statistic (κ) among a mixed group of expert and non-expert reviewers using only a brief description of the scoring system to score single images from a series of patients. In the second phase we explored the effect of training on the use of our HIA scoring system by assessing IRR among neuroimaging experts before and after a brief interactive training session. In this phase, multiple slices from each patient were scored. Separate κ values and intraclass correlation coefficients (ICC) were calculated from the scores given to each hippocampal image and from the asymmetry of scores between left and right for each slice. In the third phase the effect of training on non-expert reviewers was explored using a similar approach as with the expert reviewers. RESULTS In the preliminary phase of the study, HIA scoring of single images showed substantial agreement among expert reviewers (κHIA=0.65), fair agreement among non-expert reviewers (κHIA=0.27), and a fair to moderate degree of agreement among all the reviewers as a whole (κHIA=0.40). In the second phase, prior to training there was substantial agreement among expert reviewers in regard to the individual HIA scores (κHIA=0.62; ICCHIA=0.81) but only moderate agreement on the degree of asymmetry (κAsym=0.47; ICCAsym=0.71). Training improved agreement on the individual HIA scores (κHIA=0.58-0.72; ICCHIA=0.76-0.84) and on the degree of asymmetry (κAsym=0.61-0.67; ICCAsym=0.81-0.85). Among non-expert reviewers, scores improved from only a fair degree of agreement pre-training (κHIA=0.25, κAsym=0.25; ICCHIA=0.68, ICCAsym=0.66) to a moderate level of agreement after training (κHIA=0.54, κAsym=0.52; ICCHIA=0.78, ICCAsym=0.81). CONCLUSIONS The proposed HIA scoring system has a substantial degree of inter-rater reliability among experienced neuroimaging reviewers. Training improves the detection of asymmetries in HIA score in particular. Non-expert reviewers can employ the system with a moderate degree of reliability, and training has an even greater impact on the improvement of scoring reliability.
Collapse
Affiliation(s)
- Lawrence W Ver Hoef
- UAB Epilepsy Center, Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, United States.
| | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Ver Hoef LW, Williams FB, Kennedy RE, Szaflarski JP, Knowlton RC. Predictive value of hippocampal internal architecture asymmetry in temporal lobe epilepsy. Epilepsy Res 2013; 106:155-63. [PMID: 23911210 DOI: 10.1016/j.eplepsyres.2013.05.008] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2012] [Revised: 04/13/2013] [Accepted: 05/13/2013] [Indexed: 11/28/2022]
Abstract
BACKGROUND Asymmetry of hippocampal internal architecture (HIA) clarity has been suggested to be a sign of hippocampal sclerosis (HS) and is frequently associated with other MRI findings of HS. The goal of this work is to use a previously developed HIA visual scoring system (Ver Hoef et al., 2013) to quantify HIA asymmetry in a retrospective series of consecutive temporal lobe epilepsy (TLE) patients and evaluate its value in predicting laterality of seizure onset both in patients with other signs of HS (HS+) and those without (HS-). METHODS The HIA scoring system was used to rate hippocampal asymmetry and to assess the agreement between HIA and seizure lateralization. The median values of the average HIA scores for each hippocampus were compared for HS+ epileptogenic hippocampi, HS- epileptogenic hippocampi, and non-epileptogenic hippocampi with a Kruskal-Wallis one-way analysis of variance by ranks. Pair-wise differences between groups were evaluated with the two-tailed Mann-Whitney U test. A logistic regression model examined the utility of average HIA asymmetry score in predicting the true laterality of seizure onset as determined by video-EEG. Sensitivity and specificity are calculated using various asymmetry thresholds in each patient group. RESULTS Fifty-five patients were identified who met inclusion criteria. Thirteen patients (24%) were found to have hippocampal atrophy and/or signal abnormality indicative of HS (HS+) and 42 did not (HS-). Significant differences were observed in the distribution of individual and average HIA scores between each of the groups of hippocampi, with HS+ hippocampi having the lowest HIA scores and non-epileptogenic hippocampi having the highest. Logistic regression analysis showed that the average HIA asymmetry score was a strong predictor of the laterality of seizure onset (β=3.93508, p<0.001). HIA asymmetry remained significant even after adjustment for HS+/HS- status (β=3.8854, p<0.001). Among HS- patients, when the average HIA asymmetry score was equal to or exceeded a threshold value of 0.5, the specificity for correctly predicting the side of seizure onset was between 95% and 100% with a sensitivity of 40-45%. Among HS+ patients, a threshold of 0.3 yielded a sensitivity of 85% and specificity of 100%. CONCLUSIONS In this report we show for the first time that HIA asymmetry is a significant predictor of the laterality of seizure onset in TLE patients with otherwise normal MRI findings, and that the proposed HIA scoring system has high specificity and moderate sensitivity for lateralizing seizure onset in patients with TLE.
Collapse
Affiliation(s)
- Lawrence W Ver Hoef
- UAB Epilepsy Center, Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, United States.
| | | | | | | | | |
Collapse
|
14
|
Stringer JSA, Chisembele-Taylor A, Chibwesha CJ, Chi HF, Ayles H, Manda H, Mazimba W, Schuttner L, Sindano N, Williams FB, Chintu N, Chilengi R. Protocol-driven primary care and community linkages to improve population health in rural Zambia: the Better Health Outcomes through Mentoring and Assessment (BHOMA) project. BMC Health Serv Res 2013; 13 Suppl 2:S7. [PMID: 23819614 PMCID: PMC3668289 DOI: 10.1186/1472-6963-13-s2-s7] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023] Open
Abstract
INTRODUCTION Zambia's under-resourced public health system will not be able to deliver on its health-related Millennium Development Goals without a substantial acceleration in mortality reduction. Reducing mortality will depend not only upon increasing access to health care but also upon improving the quality of care that is delivered. Our project proposes to improve the quality of clinical care and to improve utilization of that care, through a targeted quality improvement (QI) intervention delivered at the facility and community level. DESCRIPTION OF IMPLEMENTATION The project is being carried out 42 primary health care facilities that serve a largely rural population of more than 450,000 in Zambia's Lusaka Province. We have deployed six QI teams to implement consensus clinical protocols, forms, and systems at each site. The QI teams define new clinical quality expectations and provide tools needed to deliver on those expectations. They also monitor the care that is provided and mentor facility staff to improve care quality. We also engage community health workers to actively refer and follow up patients. EVALUATION DESIGN Project implementation occurs over a period of four years in a stepped expansion to six randomly selected new facilities every three months. Three annual household surveys will determine population estimates of age-standardized mortality and under-5 mortality in each community before, during, and after implementation. Surveys will also provide measures of childhood vaccine coverage, pregnancy care utilization, and general adult health. Health facility surveys will assess coverage of primary health interventions and measures of health system effectiveness. DISCUSSION The patient-provider interaction is an important interface where the community and the health system meet. Our project aims to reduce population mortality by substantially improving this interaction. Our success will hinge upon the ability of mentoring and continuous QI to improve clinical service delivery. It will also be critical that once the quality of services improves, increasing proportions of the population will recognize their value and begin to utilize them.
Collapse
Affiliation(s)
- Jeffrey SA Stringer
- Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill, NC, USA
| | - Angela Chisembele-Taylor
- Primary Care and Health Systems Department, Centre for Infectious Disease Research, Lusaka, Zambia
| | - Carla J Chibwesha
- Primary Care and Health Systems Department, Centre for Infectious Disease Research, Lusaka, Zambia
| | - Harmony F Chi
- Development Department, Centre for Infectious Disease Research, Lusaka, Zambia
| | - Helen Ayles
- ZAMBART PROJECT, Zambia AIDS Related Tuberculosis Project, Lusaka, Zambia
| | - Handson Manda
- Primary Care and Health Systems Department, Centre for Infectious Disease Research, Lusaka, Zambia
| | - Wendy Mazimba
- Primary Care and Health Systems Department, Centre for Infectious Disease Research, Lusaka, Zambia
| | - Linnaea Schuttner
- Primary Care and Health Systems Department, Centre for Infectious Disease Research, Lusaka, Zambia
| | - Ntazana Sindano
- Primary Care and Health Systems Department, Centre for Infectious Disease Research, Lusaka, Zambia
| | - Frank B Williams
- School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Namwinga Chintu
- Primary Care and Health Systems Department, Centre for Infectious Disease Research, Lusaka, Zambia
| | - Roma Chilengi
- Primary Care and Health Systems Department, Centre for Infectious Disease Research, Lusaka, Zambia
| |
Collapse
|
15
|
Stringer JSA, Mwango AJ, Giganti MJ, Mulenga L, Levy JW, Stringer EM, Mulenga P, Saag MS, Musonda P, Williams FB, Reid SE, Chi BH. Effectiveness of generic and proprietary first-line anti-retroviral regimens in a primary health care setting in Lusaka, Zambia: a cohort study. Int J Epidemiol 2012; 41:448-59. [PMID: 22493326 PMCID: PMC3324461 DOI: 10.1093/ije/dys022] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
Abstract
Background Although generic anti-retroviral drugs are in common use throughout the developing world, studies comparing their clinical effectiveness with that of proprietary formulations are lacking. Methods We analysed observational data from a large cohort of adults on anti-retroviral therapy (ART) to assess potential differences between generic and proprietary zidovudine (ZDV) formulations in post-90-day mortality, ‘programme failure’ (a composite of death, follow-up losses and withdrawals) and other clinical outcomes. We accounted for drug exposure in three ways: an ‘initial dispensation’ approach that categorized patients according to the first prescription; ‘time-varying’ approach that attributed an outcome to the formulation taken at the time of event; and ‘predominant exposure’ approach that considered only those with >75% exposure to either brand or generic ZDV. Proprietary formulations were used as the reference group in all adjusted Cox proportional hazard regressions. Results Among 14 736 patients eligible for analysis, 7277 (49%) initiated a generic formulation of ZDV and 7459 (51%) initiated a proprietary formulation. When categorized according to initial dispensation, no difference in post-90-day mortality was observed between the two groups [adjusted hazard ratio (AHR): 0.93, 95% confidence interval (CI): 0.77–1.12]. Similar findings were noted when drug formulation was treated as a time-varying exposure (AHR: 1.15, 95% CI: 0.89–1.48) when analysis was limited to those with a predominant exposure to one formulation or the other (AHR: 0.59, 95% CI: 0.24–1.49). Results were consistent across all approaches when programme failure was considered as an outcome. No longitudinal differences were detected between formulations for CD4 response, weight change and haemoglobin concentration. Generic ZDV formulations were associated with slight decreases in single-drug substitution. Conclusions In this large programmatic cohort of adults starting ZDV-based first-line therapy, clinical outcomes appeared similar among patients on generic or proprietary formulations. These findings support continued use of generic anti-retroviral drug formulations in resource-constrained settings.
Collapse
|
16
|
|
17
|
|